Nymox Pharmaceutical Corporation (NYM.SG)
| Previous Close | 1.7500 |
| Open | 1.7200 |
| Bid | 1.7900 x N/A |
| Ask | 1.8300 x N/A |
| Day's Range | 1.7100 - 1.7500 |
| 52 Week Range | 1.0700 - 2.7800 |
| Volume | |
| Avg. Volume | 38 |
| Market Cap | 148.707M |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1740 |
| Earnings Date | May 06, 2024 - May 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireNymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
IRVINE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets - NYMXF) is pleased to report that the Bahamas Supreme Court has issued a formal Order officially putting an end to the Bahamas litigation brought by terminated ex-employees. The Order also awards to Nymox its costs incurred in defending the ill-conceived lawsuit, as well as damages Nymox has suffered as a result of the litigation. The Court order states the following: The Interim Injunctio
- GlobeNewswire
Nymox December 27 Message to Shareholders
IRVINE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) is pleased to provide this end-of-the year message to shareholders. The Company has overall had a good year and we expect 2024 to be an even better year for our Shareholders. 2023 saw our 2nd and 3rd applications for Nymozarfex advance to the level of being accepted for review. While the outcomes from these 2 applications cannot be guaranteed, these are very solid advances for which w
- GlobeNewswire
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
IRVINE, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that the California Superior Court, Orange County (OCSC) has issued an order granting Nymox’s preliminary injunction against Randall Lanham, Richard Cutler, Christopher Riley, and the Committee to Restore Nymox Shareholder Value. The Court ordered that the above defendants and their officers, agents, servants, employees, assigns, and all those acting in active concert
